title: Response: Is heart failure a debatable end-point for bisphosphonate treatment in an older osteoporotic population?
authors.affiliation: Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark.
authors.forename: E L
authors.initials: EL
authors.lastname: Grove
authors.forename: B
authors.initials: B
authors.lastname: Abrahamsen
authors.forename: P
authors.initials: P
authors.lastname: Vestergaard
mesh_terms: D050071:Bone Density Conservation Agents / Q000009:adverse effects*; D004164:Diphosphonates / Q000009:adverse effects*; D005260:Female; D006333:Heart Failure / Q000139:chemically induced*; D006801:Humans; D008297:Male
chemical_list: D050071:Bone Density Conservation Agents; D004164:Diphosphonates